Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 14, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Expands Collaboration With Netherlands Cancer Institute (NKI)

SANTA MONICA, Calif., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today announced that it has expanded its collaboration with the Netherlands Cancer Institute (NKI). Kite...
September 11, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Receives Positive Opinion for Orphan Drug Designation in the European Union for KTE-C19, Kite's Lead Cancer T-Cell Immunotherapy

SANTA MONICA, Calif., Sept. 11, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has...
September 03, 2015 16:19 ET | Source: Kite Pharma, Inc.

Kite Pharma Commends Honors Conferred to Scientific Advisory Board Members for Their Significant Contributions to Medicine

Kite SAB Chair Dr. Owen Witte Reappointed to US Cancer Panel Prof. Zelig Eshhar Received Israel Prize, the Nation's Highest Honor Dr. James Economou Elected to the National Academy of...
September 03, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Participate in Upcoming Investor Conferences in September 2015

SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that the management team will participate in two upcoming investor conferences this...
August 17, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Provides Update on KTE-C19 Clinical Trial

Kite KTE-C19 Trial on Track to Advance to Pivotal Phase 2 Kite to Host Conference Call and Webcast on August 17, 2015 at 9:00am Eastern Time SANTA MONICA, Calif., Aug. 17, 2015 (GLOBE NEWSWIRE)...
August 14, 2015 16:30 ET | Source: Kite Pharma, Inc.

Kite Pharma to Hold Conference Call to Provide a Corporate Update on Monday, August 17, 2015

SANTA MONICA, Calif., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today announced that it will host a live conference call on Monday, August 17, 2015, at 9:00am Eastern...
August 10, 2015 16:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Reports Second Quarter 2015 Financial Results

SANTA MONICA, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
August 06, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Host Second Quarter 2015 Financial Results Conference Call and Webcast

SANTA MONICA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will host a conference call and live webcast discussion at 4:30 p.m. Eastern Time...
August 05, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Present at the Canaccord Genuity 35th Annual Growth Conference

SANTA MONICA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present a company overview at the Canaccord Genuity 35th Annual Growth...
July 01, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma and The Leukemia & Lymphoma Society(R) Enter Into Collaboration to Enhance the Development of KTE-C19 in Refractory Aggressive Non-Hodgkin Lymphoma and Launch CAR T-Cell Therapy Educational Programs

SANTA MONICA, Calif. and WHITE PLAINS, N.Y., July 1, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) and The Leukemia & Lymphoma Society (LLS) announced today that they have entered into...